当前位置:首页 - 行情中心 - 奥精医疗(688613) - 财务分析 - 现金流量表

奥精医疗

(688613)

  

流通市值:28.26亿  总市值:28.26亿
流通股本:1.37亿   总股本:1.37亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金90,754,003.6241,563,608.49296,058,328.29189,844,695.76
  收到的税费返还203,076.83114,890.243,209,435.27919,556.99
  收到其他与经营活动有关的现金802,036.51237,836.325,254,626.618,890,227.27
  经营活动现金流入小计91,759,116.9641,916,335.05304,522,390.17199,654,480.02
  购买商品、接受劳务支付的现金49,792,807.1720,228,453.3796,295,788.473,123,632.94
  支付给职工以及为职工支付的现金48,499,532.4827,861,385.1479,131,046.9163,908,717.8
  支付的各项税费19,413,665.8711,349,187.2428,593,037.1423,077,450.92
  支付其他与经营活动有关的现金25,499,928.7413,651,980.3861,010,663.3344,041,770.89
  经营活动现金流出小计143,205,934.2673,091,006.13265,030,535.78204,151,572.55
  经营活动产生的现金流量净额平衡项目00.0100
  经营活动产生的现金流量净额-51,446,817.3-31,174,671.0739,491,854.39-4,497,092.53
二、投资活动产生的现金流量:
  收回投资收到的现金6,000,000-25,000,00025,000,000
  取得投资收益收到的现金167,137.62-124,271.6439,774.48
  处置固定资产、无形资产和其他长期资产收回的现金净额41390357227
  投资活动现金流入小计6,167,550.629025,124,628.6425,040,001.48
  购建固定资产、无形资产和其他长期资产支付的现金5,070,934.461,214,756.5628,927,434.2317,968,305.54
  投资支付的现金--30,000,00030,000,000
  投资活动现金流出小计5,070,934.461,214,756.5658,927,434.2347,968,305.54
  投资活动产生的现金流量净额1,096,616.16-1,214,666.56-33,802,805.59-22,928,304.06
三、筹资活动产生的现金流量:
  吸收投资收到的现金--14,705,486.4314,705,486.43
  取得借款收到的现金15,000,000---
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计15,000,000-14,705,486.4314,705,486.43
  偿还债务支付的现金32,860,00032,860,0004,692,173.333,692,173.33
  分配股利、利润或偿付利息支付的现金386,055.56266,315.562,280,433.191,745,187.62
  支付其他与筹资活动有关的现金1,718,925.06230,355.41,468,052.911,023,898.28
  筹资活动现金流出小计34,964,980.6233,356,670.968,440,659.436,461,259.23
  筹资活动产生的现金流量净额-19,964,980.62-33,356,670.966,264,8278,244,227.2
四、汇率变动对现金及现金等价物的影响-58,768.74-23,176.06395,521.51409,595.3
五、现金及现金等价物净增加额-70,373,950.5-65,769,184.6512,349,397.31-18,771,574.09
  加:期初现金及现金等价物余额169,063,830.02169,063,830.02156,714,432.71156,714,432.71
  期末现金及现金等价物余额98,689,879.52103,294,645.37169,063,830.02137,942,858.62
补充资料:
  净利润1,175,650.85-9,502,355-
  资产减值准备--161,868.18-
  固定资产和投资性房地产折旧9,543,253.55-18,291,281.65-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧9,543,253.55-18,291,281.65-
  无形资产摊销860,314.56-1,926,510.45-
  长期待摊费用摊销3,328,925.03-9,431,337.27-
  处置固定资产、无形资产和其他长期资产的损失92,981.99--464,678.56-
  公允价值变动损失-5,871,190.11--13,054,629.26-
  财务费用587,324.99-2,381,895.43-
  投资损失-167,137.62--124,271.64-
  递延所得税-11,288.44-3,686,317.85-
  其中:递延所得税资产减少--1,151,125.13-
    递延所得税负债增加-11,288.44-2,535,192.72-
  存货的减少753,308.16--22,239,720.6-
  经营性应收项目的减少-41,278,416.79-29,991,126.62-
  经营性应付项目的增加-23,063,868.91-2,806,085.75-
  现金的期末余额98,689,879.52-169,063,830.02-
  减:现金的期初余额169,063,830.02-156,714,432.71-
  现金及现金等价物的净增加额-70,373,950.5-12,349,397.31-
公告日期2026-08-292026-04-292026-04-292025-10-30
审计意见(境内)标准无保留意见
TOP↑